Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer

(2019) Chunhua Xu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Using prognosis to guide inclusion criteria, define standardized end-points and stratify follow up in active surveillance for prostate cancer

(2019) Vincent J Gnanapragasam et al.   BJU INTERNATIONAL

Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management

(2019) Kevin M. Koo et al.   Nature Reviews Urology

Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study

(2019) Renata Zelic et al.   EUROPEAN UROLOGY

The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study

(2018) V. J. Gnanapragasam et al.   BMC Medicine

Screening for Prostate Cancer

(2018) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer

(2018) Debashis Sahoo et al.   Oncotarget

A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer

(2018) Jiupeng Zhou et al.   PLoS One

Diagnostic characteristics of lethal prostate cancer

(2017) John Thomas Helgstrand et al.   EUROPEAN JOURNAL OF CANCER

Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma

(2017) Pei-song Bai et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Identifying intermediate-risk candidates for active surveillance of prostate cancer

(2017) Richard Savdie et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Implications of pleiotrophin in human PC3 prostate cancer cell growthin vivo

(2012) Sotiria Tsirmoula et al.   CANCER SCIENCE

The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells

(2011) Yamina Hamma-Kourbali et al.   BMC CANCER

Lung cancer cell migration is regulated via repressing growth factor PTN/RPTP β/ζ signaling by menin

(2010) Z-J Feng et al.   ONCOGENE

Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia

(2010) Brigid Orr et al.   PROSTATE

Heparin-Binding Protein Pleiotrophin: An Important player in the Angiogenic Process

(2008) Constantinos Mikelis et al.   CONNECTIVE TISSUE RESEARCH